HOME >> MEDICINE >> NEWS
ESC releases updated Guidelines for the Management of Stable Angina Pectoris

The European Society of Cardiology released today new Guidelines for the Management of Stable Angina Pectoris. The updated Guidelines include information on new developments in cardiovascular care, advances that have been made in improving the prognosis of coronary artery disease including the use of statins and ACE inhibitors, as well as strategies to alleviate symptoms.

The Guidelines also provide updated information in the area of risk stratification and define which patients should go on for invasive investigation and treatment.

"Stable angina pectoris is responsible for considerable morbidity and mortality throughout the world," said Professor Kim Fox, chairperson of the ESC Guidelines on the Management of Stable Angina Pectoris. "Improvements in the investigation, management and treatment of this condition has been one of the most remarkable success stories in the last decade. The last European guidelines were published in 1997 and therefore these guidelines provide a new landmark in our mission to reduce the burden of cardiovascular disease in Europe."

Guidelines are critical to appropriate clinical practice, comprising specific recommendations on treatment methods, collated by senior European experts and opinion leaders in the field. For maximal relevance, Guidelines must be well presented, practical and relevant to the clinician on both a national and local level. The formulations and continual update of such Guidelines is one of the primary activities of the ESC. The ESC aims to produce Guidelines that both encompass and allow for national variations across Europe and works with its National Cardiac Society members to facilitate national adaptations and translations of each Guideline issued.


'"/>

Contact: Lisa Abdolian
labdolian@escardio.org
33-049-294-8627
European Society of Cardiology
31-May-2006


Page: 1

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. JRRD releases single-topic issue on pain and pain management
3. American College of Physicians releases new patient education resources
4. JRRD releases single-topic issue focused on vision rehabilitation
5. The AGA Institute releases report on the future of gastroenterology
6. Osteoarthritis initiative releases first data
7. The ESC releases guidance document on Cardiac Rhythm Management product performance
8. Heart Rhythm Society releases draft recommendations on pacemakers, ICDs on April 26
9. ACP releases annual report on The State of the Nations Health Care
10. USP releases national report
11. CIHR releases research results to inform the development of benchmarks for wait times

Post Your Comments:
(Date:5/21/2013)... Dubuque, IA (PRWEB) May 21, 2013 Nearly ... took time out of an award trip in Los Cabos, ... Dia, a “day house” for the elderly. , The facility ... elderly residents of San Jose del Cabo, Mexico. , Platinum ... project began while reflecting on the company’s history. , “Platinum ...
(Date:5/21/2013)... Everspark Interactive, one of the city's leading ... over the past year – and announced another milestone ... marketing efforts for Kids II, a designer of innovative ... a local effort, specializing in search engine optimization (SEO) ... company's website. The company now offers a host of ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Workplace ... world’s leading work-life services provider, and Mayo Clinic ... wellness services. In an initiative set to launch ... Clinic’s coaching model into its existing suite of ... Clinic’s current commercial client base in addition to ...
(Date:5/21/2013)... AAG Health, the leading age management and hormone ... has acquired the OligoScan test made by leading European ... technology, the OligoScan device is capable of measuring in ... metals, 20 trace elements (minerals), and oxidative stress levels. ... as mercury, lead, aluminum, and arsenic, will make it ...
(Date:5/21/2013)... Thousands of Americans, many of them smokers or ... chronic obstructive pulmonary disease (COPD). Now a new ... antibiotic azithromycin may be able to cut down ... "Given that exacerbations of COPD can be ... Victoria Richards, assistant professor of medical science at ...
Breaking Medicine News(10 mins):Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 3Health News:Everspark Named Interactive Marketing Company for Kids II 2Health News:Workplace Options and Mayo Clinic Announce Strategic Relationship 2Health News:Workplace Options and Mayo Clinic Announce Strategic Relationship 3Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 2Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 3Health News:Long-Term Use of Antibiotic May Help Those With COPD 2Health News:Long-Term Use of Antibiotic May Help Those With COPD 3
(Date:5/21/2013)... May 21, 2013  Lehigh Valley Health Network has ... devices, adding to its existing arsenal of five ... up residence within the network, LVHN is now deploying ... proactively combat superbugs and provide the best possible patient ... Ultraviolet Disinfector, TRU-D – the signature product of ...
(Date:5/21/2013)...  Janssen R&D Ireland (Janssen) today announced primary ... 3 PROMISE study demonstrating that use of the ... virologic response 12 weeks after the end of ... 1 chronic hepatitis C adult patients with compensated ... when administered once daily with pegylated interferon and ...
(Date:5/21/2013)... , May 21, 2013  BioRestorative Therapies, Inc. ("BRT" ... company focused on developing stem cell based therapies for ... , its President and CEO, will be presenting ... conference will be held on Thursday, May 30, 2013 ... 42nd Street in New York City.  Mr. Weinreb,s presentation ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3
Cached News: